SPL ASX · Health Care

Starpharma Holdings Ltd

Announcements, last 12 months: 68
Price sensitive, last 12 months: 19
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
23 Oct 2026, 4:50 PM	Details of Company Address
22 Oct 2026, 10:05 AM	Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive	AI summary
22 Oct 2026, 8:38 AM	$3.5 Million R&D Tax Incentive Received
21 Oct 2026, 2:53 PM	Starpharma Investor Presentation Petalion Webinar
20 Oct 2026, 9:31 AM	Starpharma secures majority ownership of Petalion Price sensitive	AI summary
16 Oct 2026, 9:30 AM	Trading Halt Price sensitive	AI summary
7 Oct 2026, 3:03 PM	Change in substantial holding
6 Oct 2026, 2:44 PM	Notice of Annual General Meeting/Proxy Form
5 Oct 2026, 9:33 AM	Change of Director's Interest Notice - C Maley
5 Oct 2026, 9:31 AM	Application for quotation of securities - SPL

Sign in to see all SPL announcements.

Guidance history

26 Aug 2026	FY26 revenue: $12.0 million, FY26 loss: $7.5 million, FY26 R&D expenditure: $11.1 million
15 Jul 2026	Proceeds expected to extend cash runway into FY28, supporting oncology development
3 Jul 2026	Potential for Starpharma to receive up to AUD $91M in payments

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow SPL to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.